ADAM28 is activated by MMP-7 (matrilysin-1) and cleaves insulin-like growth factor binding protein-3
- 1 February 2004
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 315 (1) , 79-84
- https://doi.org/10.1016/j.bbrc.2004.01.022
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology (B2-11240206)
This publication has 30 references indexed in Scilit:
- Catalytic Activity of ADAM8, ADAM15, and MDC-L (ADAM28) on Synthetic Peptide Substrates and in Ectodomain Cleavage of CD23Journal of Biological Chemistry, 2003
- Integrin α4β1-Dependent Adhesion to ADAM 28 (MDC-L) Requires an Extended Surface of the Disintegrin DomainBiochemistry, 2003
- The Lymphocyte Metalloprotease MDC-L (ADAM 28) Is a Ligand for the Integrin α4β1Journal of Biological Chemistry, 2002
- Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF‐induced angiogenesisThe FASEB Journal, 2001
- Catalytic activity of ADAM28FEBS Letters, 2001
- ADAM 12-S Cleaves IGFBP-3 and IGFBP-5 and Is Inhibited by TIMP-3Biochemical and Biophysical Research Communications, 2000
- TNF‐α converting enzyme (TACE) is inhibited by TIMP‐3FEBS Letters, 1998
- Mitogenic Signaling of Insulin-like Growth Factor I in MCF-7 Human Breast Cancer Cells Requires Phosphatidylinositol 3-Kinase and Is Independent of Mitogen-activated Protein KinaseJournal of Biological Chemistry, 1997
- Matrix Metalloproteinase 7 (Matrilysin) from Human Rectal Carcinoma CellsJournal of Biological Chemistry, 1995
- Circulating binding proteins for the insulinlike growth factorsTrends in Endocrinology & Metabolism, 1993